SecBot SecBot
SECBOTREPLAY Home › Report › EBS

EBS · Emergent BioSolutions received a $52.7 million contract modification…

Emergent BioSolutions Inc. · 8-K filed Jun 29, 2026 at 11:14 ET

At the news

BULLISHIMPACT 5/10

8-K filed Jun 29, 2026 at 11:14 ET

Emergent BioSolutions received a $52.7 million contract modification from the U.S. government (ASPR) for ACAM2000 vaccine supply under an existing 10-year contract. Deliveries begin June 2026, with diluent lots by December 2026. This is a material but routine government award, providing near-term revenue visibility.

  • Contract modification valued at $52.7 million from ASPR for ACAM2000 vaccine
  • Deliveries of doses and ancillaries to begin June 2026; diluent replacement lots by December 2026
  • Modification exercises Option Year 7 under existing 10-year contract (75A50119C00071)
  • Recent international approvals: Saudi FDA and Singapore HSA expanded ACAM2000 indications for mpox

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access